XT
CTOR

XTX Topco’s Citius Oncology CTOR Stock Holding History

XTX Topco’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4K Buy
+20,638
New +$16.4K ﹤0.01% 3986
2026
Q1 		– Sell
-73,992
Closed -$74K – 4520
2025
Q4 		$74K Sell
73,992
-52,892
-42% -$75.9K ﹤0.01% 2726
2025
Q3 		$258K Buy
+126,884
New +$275K 0.01% 1626
2025
Q1 		– Sell
-21,095
Closed -$24.3K – 3242
2024
Q4 		$24.3K Buy
+21,095
New +$23.7K ﹤0.01% 2012

Other funds holding CTOR

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco's CTOR Position: Q2 2026 in Review

XTX Topco opened a new position in Citius Oncology (CTOR) in Q2 2026: 20,638 shares worth $13.4K. The stake represents ﹤0.01% of the portfolio and ranks #3986 among its holdings. This is a return to the name: XTX Topco previously reported a position in CTOR as recently as Q4 2025.

XTX Topco first reported a position in CTOR in Q4 2024 and has held it in 4 quarters since. The position peaked at $258K in Q3 2025. 19 funds tracked by Wall St. Rank hold CTOR as of Q2 2026.

  • XTX Topco held 20,638 shares of Citius Oncology worth $13.4K as of Q2 2026.
  • Citius Oncology was a new XTX Topco position in Q2 2026.
  • Citius Oncology made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3986 holding.
  • XTX Topco first reported a position in Citius Oncology in Q4 2024 and has held it in 4 quarters since.
  • XTX Topco's Citius Oncology position peaked at $258K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.